Suchergebnisse - (Subject:"Adalimumab")

PubPharm (461)

1

Additional Data in Expanded Patient Populations and New Indications Support the Practice of Biosimilar-to-Biosimilar Switching

enthalten in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy | 2024

von Cohen, H. | Bodenmueller, W.

2

Real-world outcomes following switching from anti-TNF reference products to biosimilars for the treatment of psoriasis

enthalten in: The Journal of dermatological treatment | 2023

von Ruda, R. | Kelly, K. | Feldman, S.

3

Intra-articular injections of biological disease-modifying anti-rheumatic drugs in inflammatory arthropathies : An up-to-date narrative review

enthalten in: Joint bone spine | 2023

von Al Khayyat, S. | Conticini, E. | Falsetti, P. | +7

4

Treatment with Biologic Drugs in Pediatric Behçet's Disease : A Comprehensive Analysis of the Published Data

enthalten in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy | 2023

von Batu, E. | Sener, S. | Cam, V. | +2

5

Correlation of anti-TNF-a biological therapy with periodontal conditions and osteonecrosis in autoimmune patients : A systematic review

enthalten in: The Saudi dental journal | 2023

von Majdi Abunemer, R. | Saifuddin Shaheen, R. | Abudullah Alghamdi, R.

6

Healthcare Professional (HCP) and Patient Usability Evaluation and Preferences of Two Auto-injector Devices for Self-Injection of Biosimilars, SB4 and SB5 : A Literature Review

enthalten in: Clinical drug investigation | 2023

von Corominas, H. | Young, D. | Cummings, J. | +4

7

Focus on Anti-Tumour Necrosis Factor (TNF)-α-Related Autoimmune Diseases

enthalten in: International journal of molecular sciences | 2023

von Lopetuso, L. | Cuomo, C. | Mignini, I. | +2

8

Drug-Induced Liver Injury due to Biologics and Immune Check Point Inhibitors

enthalten in: The Medical clinics of North America | 2023

von Bessone, F. | Björnsson, E.

9

Do genetics contribute to TNF inhibitor response prediction in Psoriatic Arthritis?

enthalten in: The pharmacogenomics journal | 2023

von Curry, P. | Morris, A. | Barton, A. | +1

10

Successful switching treatment of adalimumab for refractory pyoderma gangrenosum in a patient with rheumatoid arthritis with prior use of tumour necrosis factor inhibitors : A case report and review of the literature

enthalten in: Modern rheumatology case reports | 2023

von Ohmura, S. | Homma, Y. | Hanai, S. | +2

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[47]